Clinical Trial Update: A Sequential Cohort Study Exploring GELCLAIR in the Management of Oral Mucositis in Patients Receiving Radical Radiation for Head and Neck Cancer [NA]

View source ↗

Summary

A sequential cohort trial is being conducted to evaluate Gelclair for managing oral mucositis in head and neck cancer patients receiving radical radiation, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• Gelclair

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Oral Mucositis Due to Radiation | NA | Status: NOT_YET_RECRUITING